DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Activity

93 hedge funds and large institutions have $1.19B invested in Day One Biopharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+6
Holders Change %
+6.9%
% of All Funds
1.61%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
24
Increased
36
Reduced
18
Closed
17
Calls
$2.88M
Puts
$4.07M
Net Calls
-$1.19M
Net Calls Change
-$6.32M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$176M
2
State Street
2
State Street
Massachusetts
$40.9M
3
NIP
3
Nicholas Investment Partners
California
$15.2M
4
BlackRock
4
BlackRock
New York
$50.9M
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$10.1M

Top Sellers

1
CPX
1
Canaan Partners XI
California
$139M
2
DM
2
Deerfield Management
New York
$20.7M
3
AVLSA
3
Atlas Venture Life Science Advisors
Massachusetts
$164M
4
PA
4
Perceptive Advisors
New York
$0
5
Viking Global Investors
5
Viking Global Investors
Connecticut
$31.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
MIM
101
Monashee Investment Management
Massachusetts
– -$537K -30,000 Closed
OQS
102
Occudo Quantitative Strategies
Florida
– -$423K -23,619 Closed
Millennium Management
103
Millennium Management
New York
– -$314K -17,555 Closed
QT
104
Quantbot Technologies
New York
– -$51K -2,900 Closed
AW
105
ACG Wealth
Georgia
– -$32K -1,772 Closed
1 2 3 4
5